# A Study of Dotinurad Versus Allopurinol in Participants With Gout

> **NCT07089875** · PHASE3 · RECRUITING · sponsor: **Crystalys Therapeutics** · enrollment: 500 (estimated)

## Conditions studied

- Gout

## Interventions

- **DRUG:** Allopurinol
- **DRUG:** Dotinurad

## Key facts

- **NCT ID:** NCT07089875
- **Lead sponsor:** Crystalys Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2027-11-29
- **Final completion:** 2027-11-29
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07089875

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07089875, "A Study of Dotinurad Versus Allopurinol in Participants With Gout". Retrieved via MORVS 2026-10-12 from https://api.morvs.ai/clinical/NCT07089875. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*